{"id":49121,"date":"2022-10-04T12:01:47","date_gmt":"2022-10-04T10:01:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/"},"modified":"2022-10-04T12:01:47","modified_gmt":"2022-10-04T10:01:47","slug":"the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/","title":{"rendered":"The SSI Group, LLC (SSI) Announces Launch of Automated End-to-End Prior Authorization Solution"},"content":{"rendered":"
\n

\nSSI Prior Authorization powered by Myndshft is a turnkey, frictionless solution that helps healthcare providers streamline the prior authorization process.<\/i><\/b>\n<\/p>\n

MOBILE, Ala.–(BUSINESS WIRE)–#SSI<\/a>—The SSI Group, LLC<\/a> (SSI), a leading provider of revenue cycle management (RCM) solutions, today announced the launch of a turnkey, end-to-end electronic prior authorization solution for healthcare providers that connects in real-time to more than seven-hundred payers. SSI Prior Authorization, powered by Myndshft, automates the prior authorization process from beginning to end, eliminating friction while delivering immediate value in improving productivity, reducing unnecessary operating costs, and increasing revenue. Specifically for hospitals, the solution will provide prior authorization improvements enterprise-wide.\n<\/p>\n

<\/a><\/p>\n

\nPrior authorization continues to be a growing challenge across all healthcare organizations, with providers typically relying on inefficient manual efforts. According to the CAQH 2021 Index<\/a>, prior authorization has the highest cost transaction across the medical industry and is the most time-consuming transaction for providers. With SSI Prior Authorization, the entire process takes only seconds, eliminating manual work and taking 99% less time to complete the workflow.\n<\/p>\n

\n\u201cAs providers continue to face tight operational margins and work through workforce shortages, they need solutions to help improve automation, increase profitability and revenue,\u201d said Diana Allen, CEO of SSI. \u201cSSI Prior Authorization in collaboration with Myndshft is a game changer in that it improves automation and workflows, while simultaneously ensuring patients receive care when they need it.\u201d\n<\/p>\n

\n\u201cWe are excited to power the SSI Prior Authorization solution,\u201d said Ron Wince, CEO of Myndshft. \u201cThe solution, powered by Myndshft\u2019s leading edge prior authorization automation technology, expands SSI\u2019s breadth of proven revenue cycle offerings and fills a much-needed void in the healthcare space. SSI and Myndshft\u2019s goals are well-aligned as we aim to simplify and streamline RCM processes for the greater good of patients and providers.\u201d\n<\/p>\n

\nLearn more about SSI Prior Authorization at the 2022 Becker\u2019s Health IT + Digital Health + RCM Annual Meeting in Chicago from October 4\u20137 (Booth 1321).\n<\/p>\n

\nAbout The SSI Group, LLC (SSI)<\/b>\n<\/p>\n

\nThe SSI Group, LLC (SSI) empowers providers with industry-leading revenue cycle management solutions to maximize their efforts\u2014and returns\u2014at every stage. From access to claims reporting, our solutions span the revenue cycle and help clients streamline workflows, increase revenue, improve efficiencies, and reduce costs. Nearly 30% of all US hospitals trust SSI for better clean claim rates, fewer denials, and timely payments. SSI\u2019s provider portfolio includes industry-leading billing and claims management, clearinghouse, access management, claims reporting, and more. We also offer a clinical data subscription service and managed payer gateway services for payers. SSI is a privately held company with over 34 years of experience and steady growth headquartered in Mobile, Alabama. Learn more at www.thessigroup.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nKristy Boldt
\n
The SSI Group, LLC (SSI)
\n
Kristy.boldt@ssigroup.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SSI Prior Authorization powered by Myndshft is a turnkey, frictionless solution that helps healthcare providers streamline the prior authorization process. MOBILE, Ala.–(BUSINESS WIRE)–#SSI—The SSI Group, LLC (SSI), a leading provider of revenue cycle management (RCM) solutions, today announced the launch of a turnkey, end-to-end electronic prior authorization solution for healthcare providers that connects in real-time … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49121","6":"format-standard","7":"category-industry"},"yoast_head":"\nThe SSI Group, LLC (SSI) Announces Launch of Automated End-to-End Prior Authorization Solution - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The SSI Group, LLC (SSI) Announces Launch of Automated End-to-End Prior Authorization Solution - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SSI Prior Authorization powered by Myndshft is a turnkey, frictionless solution that helps healthcare providers streamline the prior authorization process. MOBILE, Ala.–(BUSINESS WIRE)–#SSI—The SSI Group, LLC (SSI), a leading provider of revenue cycle management (RCM) solutions, today announced the launch of a turnkey, end-to-end electronic prior authorization solution for healthcare providers that connects in real-time ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-04T10:01:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221004005070\/en\/1588800\/21\/SSINewLogo2021_-_High_Res_JPG_-_Blue.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"The SSI Group, LLC (SSI) Announces Launch of Automated End-to-End Prior Authorization Solution\",\"datePublished\":\"2022-10-04T10:01:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/\"},\"wordCount\":470,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005070\\\/en\\\/1588800\\\/21\\\/SSINewLogo2021_-_High_Res_JPG_-_Blue.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/\",\"name\":\"The SSI Group, LLC (SSI) Announces Launch of Automated End-to-End Prior Authorization Solution - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005070\\\/en\\\/1588800\\\/21\\\/SSINewLogo2021_-_High_Res_JPG_-_Blue.jpg\",\"datePublished\":\"2022-10-04T10:01:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005070\\\/en\\\/1588800\\\/21\\\/SSINewLogo2021_-_High_Res_JPG_-_Blue.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005070\\\/en\\\/1588800\\\/21\\\/SSINewLogo2021_-_High_Res_JPG_-_Blue.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The SSI Group, LLC (SSI) Announces Launch of Automated End-to-End Prior Authorization Solution\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The SSI Group, LLC (SSI) Announces Launch of Automated End-to-End Prior Authorization Solution - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/","og_locale":"en_US","og_type":"article","og_title":"The SSI Group, LLC (SSI) Announces Launch of Automated End-to-End Prior Authorization Solution - Pharma Trend","og_description":"SSI Prior Authorization powered by Myndshft is a turnkey, frictionless solution that helps healthcare providers streamline the prior authorization process. MOBILE, Ala.–(BUSINESS WIRE)–#SSI—The SSI Group, LLC (SSI), a leading provider of revenue cycle management (RCM) solutions, today announced the launch of a turnkey, end-to-end electronic prior authorization solution for healthcare providers that connects in real-time ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-04T10:01:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221004005070\/en\/1588800\/21\/SSINewLogo2021_-_High_Res_JPG_-_Blue.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"The SSI Group, LLC (SSI) Announces Launch of Automated End-to-End Prior Authorization Solution","datePublished":"2022-10-04T10:01:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/"},"wordCount":470,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221004005070\/en\/1588800\/21\/SSINewLogo2021_-_High_Res_JPG_-_Blue.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/","url":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/","name":"The SSI Group, LLC (SSI) Announces Launch of Automated End-to-End Prior Authorization Solution - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221004005070\/en\/1588800\/21\/SSINewLogo2021_-_High_Res_JPG_-_Blue.jpg","datePublished":"2022-10-04T10:01:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221004005070\/en\/1588800\/21\/SSINewLogo2021_-_High_Res_JPG_-_Blue.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221004005070\/en\/1588800\/21\/SSINewLogo2021_-_High_Res_JPG_-_Blue.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/the-ssi-group-llc-ssi-announces-launch-of-automated-end-to-end-prior-authorization-solution\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"The SSI Group, LLC (SSI) Announces Launch of Automated End-to-End Prior Authorization Solution"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49121"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49121\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}